June 30, 2016: Drug pricing might be dominating biomedical headlines these days, but there’s a lot more happening beneath the surface that’s driving innovation—specifically in California’s San Francisco Bay Area. In this region, a vibrant and robust biomedical industry is quickly growing.
June 30, 2016: Boehringer Ingelheim announced yesterday that it is cutting 725 jobs in the U.S., with 50 of those jobs being from its headquarters in Ridgefield, Connecticut.
June 30, 2016: Morphic Therapeutic announced today that is has completed a Series A financing round worth $51.5M. It was co-led by SR One and Pfizer Venture Investments, and joined by Omega Funds and AbbVie Ventures.
June 30, 2016: Fibrocell announced today that it is closing down its azficel-T operations and cutting 24 jobs as a result, primarily in manufacturing and quality operations.